Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Laurenza

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
British Journal of Clinical Pharmacology|April 3, 2016
Impact of perampanel on pharmacokinetics of concomitant antiepileptics in patients with partial-onset seizures: pooled analysis of clinical trialsOneeb Majid, Antonio Laurenza, Jim Ferry, et al.
Epilepsy Research|December 24, 2018
Potential protein-binding displacement interactions with perampanel: An in vitro analysisBarry E Gidal, Jim Ferry, Antonio Laurenza, et al.
Trends in Pharmacological Sciences|March 25, 2025
M1 receptor positive allosteric modulators discovery approachesTakao Mandai, Arthur A Simen, Antonio Laurenza, et al.
Epilepsy & Behavior : E&B|June 10, 2015
Perampanel in the treatment of partial seizures: Time to onset and duration of most common adverse events from pooled Phase III and extension studiesDavid Ko, Haichen Yang, Betsy Williams, et al.
Epilepsia|June 23, 2015
Perampanel efficacy and safety by gender: Subanalysis of phase III randomized clinical studies in subjects with partial seizuresBlanca Vazquez, Haichen Yang, Betsy Williams, et al.
Epilepsy & Behavior Case Reports|May 1, 2018
Evaluation of perampanel as monotherapy for focal seizures: Experience from open-label extension studiesPatrick Kwan, Scott Mintzer, Antonio Laurenza, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 4, 2020
In Vitro Metabolism of Slowly Cleared G Protein-Coupled Receptor 139 Agonist TAK-041 Using Rat, Dog, Monkey, and Human Hepatocyte Models (HepatoPac): Correlation with In Vivo MetabolismAmin Kamel, Steve Bowlin, Natalie Hosea, et al.
Epilepsy Research|May 20, 2015
Absence of Liver Toxicity in Perampanel-Treated Subjects: Pooled results from partial seizure phase III perampanel clinical studiesAntonio Laurenza, Haichen Yang, Betsy Williams, et al.
Epilepsy Research|June 20, 2015
Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trialsHaichen Yang, Antonio Laurenza, Betsy Williams, et al.
Epilepsy Research|June 20, 2015
Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanelGeorgia Montouris, Haichen Yang, Betsy Williams, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
British Journal of Clinical Pharmacology|April 3, 2016
Impact of perampanel on pharmacokinetics of concomitant antiepileptics in patients with partial-onset seizures: pooled analysis of clinical trialsOneeb Majid, Antonio Laurenza, Jim Ferry, et al.
Epilepsy Research|December 24, 2018
Potential protein-binding displacement interactions with perampanel: An in vitro analysisBarry E Gidal, Jim Ferry, Antonio Laurenza, et al.
Trends in Pharmacological Sciences|March 25, 2025
M1 receptor positive allosteric modulators discovery approachesTakao Mandai, Arthur A Simen, Antonio Laurenza, et al.
Epilepsy & Behavior : E&B|June 10, 2015
Perampanel in the treatment of partial seizures: Time to onset and duration of most common adverse events from pooled Phase III and extension studiesDavid Ko, Haichen Yang, Betsy Williams, et al.
Epilepsia|June 23, 2015
Perampanel efficacy and safety by gender: Subanalysis of phase III randomized clinical studies in subjects with partial seizuresBlanca Vazquez, Haichen Yang, Betsy Williams, et al.
Epilepsy & Behavior Case Reports|May 1, 2018
Evaluation of perampanel as monotherapy for focal seizures: Experience from open-label extension studiesPatrick Kwan, Scott Mintzer, Antonio Laurenza, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 4, 2020
In Vitro Metabolism of Slowly Cleared G Protein-Coupled Receptor 139 Agonist TAK-041 Using Rat, Dog, Monkey, and Human Hepatocyte Models (HepatoPac): Correlation with In Vivo MetabolismAmin Kamel, Steve Bowlin, Natalie Hosea, et al.
Epilepsy Research|May 20, 2015
Absence of Liver Toxicity in Perampanel-Treated Subjects: Pooled results from partial seizure phase III perampanel clinical studiesAntonio Laurenza, Haichen Yang, Betsy Williams, et al.
Epilepsy Research|June 20, 2015
Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trialsHaichen Yang, Antonio Laurenza, Betsy Williams, et al.
Epilepsy Research|June 20, 2015
Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanelGeorgia Montouris, Haichen Yang, Betsy Williams, et al.
Pageof 5